Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 899 -5.78%
22 May - close price
medplusindia.com BSE: 543427 NSE: MEDPLUS
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,930 stores across 13 states and 1 union territory, serving 750 cities as of Q2 FY26. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[2]
  • Telangana: 781 stores
  • Andhra Pradesh: 569 stores
  • Karnataka: 997 stores
  • Tamil Nadu: 1014 stores
  • West Bengal: 691 stores
  • Maharashtra: 587 stores
  • Odisha: 179 stores
  • Chhattisgarh: 45 stores
  • Madhya Pradesh: 33 stores
  • Puducherry: 5 stores
  • Delhi: 1 store
    They added 218 net new stores in H1 FY2026, of which 121 were in Tier-2 and Tier-3 cities. 28 stores were closed in Q2 FY26, out of which 13 closed due to relocation, 5 closed due to franchisee withdrawal, 10 closed due to other reasons.[3][4]
Website BSE NSE
  • Market Cap ₹ 10,790 Cr.
  • Current Price ₹ 899
  • High / Low ₹ 1,052 / 732
  • Stock P/E 49.1
  • Book Value ₹ 165
  • Dividend Yield 0.00 %
  • ROCE 12.6 %
  • ROE 11.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 28.6% CAGR over last 5 years

Cons

  • Stock is trading at 5.46 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.48% over last 3 years.
  • Promoters have pledged 60.7% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of BSE 500 BSE Consumer Discretionary BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
1,253 1,284 1,409 1,441 1,490 1,489 1,576 1,561 1,510 1,543 1,679 1,806 1,864
1,171 1,213 1,324 1,350 1,385 1,395 1,452 1,429 1,373 1,412 1,530 1,648 1,695
Operating Profit 82 71 85 92 106 94 124 133 136 131 149 159 169
OPM % 7% 6% 6% 6% 7% 6% 8% 8% 9% 8% 9% 9% 9%
14 9 10 10 10 9 12 13 16 15 17 18 21
Interest 22 23 24 24 25 25 25 26 27 27 29 31 33
Depreciation 56 52 55 57 59 60 63 62 64 66 69 73 76
Profit before tax 17 5 16 20 32 18 48 57 61 53 69 73 80
Tax % -54% 26% 12% 31% -5% 19% 19% 19% 16% 20% 19% 21% 20%
27 4 15 14 34 14 39 46 51 42 56 58 64
EPS in Rs 2.23 0.32 1.22 1.15 2.79 1.20 3.24 3.83 4.29 3.54 4.63 4.82 5.33
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1,368 1,733 2,011 2,131 2,273 2,871 3,069 3,779 4,558 5,625 6,136 6,892
1,336 1,696 1,940 2,073 2,153 2,737 2,852 3,507 4,292 5,270 5,648 6,285
Operating Profit 32 37 71 58 120 134 217 273 266 355 488 607
OPM % 2% 2% 4% 3% 5% 5% 7% 7% 6% 6% 8% 9%
4 8 7 8 11 17 21 31 46 40 48 71
Interest 14 17 19 28 50 47 55 66 83 96 103 120
Depreciation 9 10 11 12 59 75 88 119 182 224 250 283
Profit before tax 14 19 48 26 23 29 95 118 47 73 183 275
Tax % 46% 52% 40% -65% 48% 94% 34% 20% -6% 11% 18% 20%
7 9 29 42 12 2 63 95 50 66 150 220
EPS in Rs 419.34 508.71 1,620.57 2,080.06 585.46 107.02 1,393.11 8.03 4.17 5.48 12.56 18.30
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 15%
5 Years: 18%
3 Years: 15%
TTM: 12%
Compounded Profit Growth
10 Years: 37%
5 Years: 29%
3 Years: 67%
TTM: 50%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 3%
1 Year: -6%
Return on Equity
10 Years: 8%
5 Years: 8%
3 Years: 8%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24 24
Reserves 141 137 148 303 291 528 730 1,394 1,467 1,554 1,717 1,951
170 223 204 162 429 477 590 815 900 1,010 1,120 1,424
126 149 183 179 239 344 245 361 406 417 500 533
Total Liabilities 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,360 3,933
67 77 81 83 377 419 517 799 1,138 1,242 1,296 1,595
CWIP 3 3 2 1 1 5 6 20 25 11 16 32
Investments 0 0 0 0 0 0 0 0 0 0 0 0
368 429 453 560 580 924 1,043 1,775 1,633 1,752 2,047 2,306
Total Assets 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,360 3,933

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-19 -17 34 32 147 -7 3 170 90 144 540 496
-16 -32 -15 -18 -19 -28 -35 -703 429 -83 -318 -128
67 35 -29 -1 -83 90 -6 440 -170 -198 -228 -256
Net Cash Flow 32 -15 -10 14 45 56 -37 -93 350 -137 -5 112
Free Cash Flow -35 -35 19 32 125 -37 -51 56 -78 61 482 373
CFO/OP -26% -19% 70% 96% 133% 6% 15% 75% 39% 49% 120% 94%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 1 1 0 2 1 1 1 1 1 1 1 1
Inventory Days 84 82 76 76 78 101 113 112 117 111 106 99
Days Payable 34 29 25 27 31 37 22 30 27 21 24 22
Cash Conversion Cycle 51 53 51 51 48 65 91 82 91 92 83 79
Working Capital Days 16 12 14 13 8 25 46 100 58 58 54 49
ROCE % 11% 19% 13% 12% 9% 13% 10% 5% 7% 10% 13%

Insights

In beta
Mar 2010 Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Pharmacy Store Count
Number

Log in to view insights

Please log in to see hidden values.

Login
Private Label Revenue Contribution
%
Total SKU Count in Warehouse
Number
Omnichannel Revenue Contribution
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
40.43% 40.41% 40.45% 40.39% 40.39% 40.39% 40.39% 40.33% 40.32% 40.29% 40.29% 40.22%
4.87% 12.36% 12.96% 14.94% 14.85% 14.72% 15.23% 15.61% 16.43% 16.53% 16.83% 15.53%
28.13% 25.50% 25.19% 22.47% 22.17% 27.98% 25.66% 26.19% 26.03% 26.51% 26.58% 27.82%
26.42% 21.61% 21.31% 22.10% 22.51% 16.85% 18.68% 17.82% 17.18% 16.60% 16.27% 16.41%
0.15% 0.12% 0.10% 0.10% 0.08% 0.07% 0.05% 0.05% 0.05% 0.05% 0.04% 0.04%
No. of Shareholders 70,01766,43066,04874,97676,93487,32883,91283,43981,74278,33779,15777,278

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls